Yahoo Web Search

Search results

    • Elion secures $81m to advance antifungal therapy

      Elion secures $81m to advance antifungal therapy

      Pharmaceutical Technology via Yahoo Finance· 11 hours ago

      Elion’s antifungal therapy SF001 targets aspergillosis, which can be caused by Aspergillus fumigatus, a pathogen of critical priority as per the WHO.